Inhibition of wild-type and mutant Bcr-Abl by AP23464, a potent ATP-based oncogenic protein kinase inhibitor: implications for CML. (Q34333693)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q59097883)
(Q373427)
(P304) 2532-2539
(P407) (Q1860)
(P433) 8
(P478) 104
(P577) Thursday, July 15, 2004
(P1433) (Q885070)
(P1476) "Inhibition of wild-type and mutant Bcr-Abl by AP23464, a potent ATP-based oncogenic protein kinase inhibitor: implications for CML." (language: en)
(P2093) Thomas O'Hare
Roy Pollock
Eric P Stoffregen
Jeffrey A Keats
Omar M Abdullah
Victor M Rivera
Hao Tang
Chester A Metcalf
Regine S Bohacek
Yihan Wang
Raji Sundaramoorthi
William C Shakespeare
David Dalgarno
Tim Clackson
Tomi K Sawyer
Michael W Deininger
other details
description scientific article

External Links